Compile Data Set for Download or QSAR
Report error Found 159 Enz. Inhib. hit(s) with all data for entry = 3426
TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256482BDBM256482(US9487512, 27 | US10329256, Example 27 | US9944601...)
Affinity DataIC50: 8nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 388464BDBM388464(US10329256, Example 4 | US9944601, Example 4)
Affinity DataIC50: 19nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 50142189BDBM50142189(US9487512, 5 | CHEMBL3759239 | US10329256, Example...)
Affinity DataIC50: 22nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256484BDBM256484(US9487512, 29 | US10329256, Example 29 | US9944601...)
Affinity DataIC50: 23nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256498BDBM256498(US9487512, 43 | US10329256, Example 43 | US9944601...)
Affinity DataIC50: 32nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256481BDBM256481(US9487512, 26 | US10329256, Example 26 | US9944601...)
Affinity DataIC50: 35nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256497BDBM256497(US9487512, 42 | US10329256, Example 42 | US9944601...)
Affinity DataIC50: 37nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256461BDBM256461(US9487512, 6 | US10329256, Example 6 | US9944601, ...)
Affinity DataIC50: 38nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256475BDBM256475(US9487512, 20 | US10329256, Example 20 | US9944601...)
Affinity DataIC50: 38nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256486BDBM256486(US9487512, 31 | US10329256, Example 31 | US9944601...)
Affinity DataIC50: 42nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256459BDBM256459(US9487512, 3 | US10329256, Example 3 | US9944601, ...)
Affinity DataIC50: 42nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256479BDBM256479(US9487512, 24 | US10329256, Example 24 | US9944601...)
Affinity DataIC50: 47nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256470BDBM256470(US9487512, 15 | US10329256, Example 15 | US9944601...)
Affinity DataIC50: 48nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 50142189BDBM50142189(US9487512, 5 | CHEMBL3759239 | US10329256, Example...)
Affinity DataKi:  55nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256459BDBM256459(US9487512, 3 | US10329256, Example 3 | US9944601, ...)
Affinity DataKi:  55nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 388464BDBM388464(US10329256, Example 4 | US9944601, Example 4)
Affinity DataKi:  55nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256461BDBM256461(US9487512, 6 | US10329256, Example 6 | US9944601, ...)
Affinity DataKi:  55nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256458BDBM256458(US9487512, 2 | US10329256, Example 2 | US9944601, ...)
Affinity DataKi:  55nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256458BDBM256458(US9487512, 2 | US10329256, Example 2 | US9944601, ...)
Affinity DataIC50: 56nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256491BDBM256491(US9487512, 36 | US10329256, Example 36 | US9944601...)
Affinity DataIC50: 68nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256468BDBM256468(US9487512, 13 | US10329256, Example 13 | US9944601...)
Affinity DataIC50: 69nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256469BDBM256469(US9487512, 14 | US10329256, Example 14 | US9944601...)
Affinity DataIC50: 71nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256499BDBM256499(US9487512, 44 | US10329256, Example 44 | US9944601...)
Affinity DataIC50: 72nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256473BDBM256473(US9487512, 18 | US10329256, Example 18 | US9944601...)
Affinity DataIC50: 81nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256483BDBM256483(US9487512, 28 | US10329256, Example 28 | US9944601...)
Affinity DataIC50: 84nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256480BDBM256480(US9487512, 25 | US10329256, Example 25 | US9944601...)
Affinity DataIC50: 97nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256489BDBM256489(US9487512, 34 | US10329256, Example 34 | US9944601...)
Affinity DataIC50: 104nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256474BDBM256474(US9487512, 19 | US10329256, Example 19 | US9944601...)
Affinity DataIC50: 105nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256472BDBM256472(US9487512, 17 | US10329256, Example 17 | US9944601...)
Affinity DataIC50: 107nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256493BDBM256493(US9487512, 38 | US10329256, Example 38 | US9944601...)
Affinity DataIC50: 108nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256477BDBM256477(US9487512, 22 | US10329256, Example 22 | US9944601...)
Affinity DataIC50: 111nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256462BDBM256462(US9487512, 7 | US10329256, Example 7 | US9944601, ...)
Affinity DataIC50: 111nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256485BDBM256485(US9487512, 30 | US10329256, Example 30 | US9944601...)
Affinity DataIC50: 111nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256465BDBM256465(US9487512, 10 | US10329256, Example 10 | US9944601...)
Affinity DataIC50: 119nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256476BDBM256476(US9487512, 21 | US10329256, Example 21 | US9944601...)
Affinity DataIC50: 127nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256471BDBM256471(US9487512, 16 | US10329256, Example 16 | US9944601...)
Affinity DataIC50: 139nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256492BDBM256492(US9487512, 37 | US10329256, Example 37 | US9944601...)
Affinity DataIC50: 153nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256496BDBM256496(US9487512, 41 | US10329256, Example 41 | US9944601...)
Affinity DataIC50: 177nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256495BDBM256495(US9487512, 40 | US10329256, Example 40 | US9944601...)
Affinity DataIC50: 188nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256488BDBM256488(US9487512, 33 | US10329256, Example 33 | US9944601...)
Affinity DataIC50: 212nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256464BDBM256464(US9487512, 9 | US10329256, Example 9 | US9944601, ...)
Affinity DataIC50: 296nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256458BDBM256458(US9487512, 2 | US10329256, Example 2 | US9944601, ...)
Affinity DataIC50: 491nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256490BDBM256490(US9487512, 35 | US10329256, Example 35 | US9944601...)
Affinity DataIC50: 549nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256464BDBM256464(US9487512, 9 | US10329256, Example 9 | US9944601, ...)
Affinity DataKi:  550nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256462BDBM256462(US9487512, 7 | US10329256, Example 7 | US9944601, ...)
Affinity DataKi:  550nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256458BDBM256458(US9487512, 2 | US10329256, Example 2 | US9944601, ...)
Affinity DataKi:  550nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256462BDBM256462(US9487512, 7 | US10329256, Example 7 | US9944601, ...)
Affinity DataIC50: 700nMAssay Description:Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256466BDBM256466(US9487512, 11 | US10329256, Example 11 | US9944601...)
Affinity DataIC50: 908nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256483BDBM256483(US9487512, 28 | US10329256, Example 28 | US9944601...)
Affinity DataIC50: 1.02E+3nMAssay Description:Human recombinant monoamine oxidase proteins MAO-A and MAO-B were purchased from Sigma Aldrich. MAOs catalyze the oxidative deamination of primary, s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

TargetLysine-specific histone demethylase 1A(Human)
Oryzon Genomics

US Patent
LigandChemical structure of BindingDB Monomer ID 256487BDBM256487(US9487512, 32 | US10329256, Example 32 | US9944601...)
Affinity DataIC50: 1.68E+3nMAssay Description:The compounds of the invention can be tested for their ability to inhibit LSD1. The ability of the compounds of the invention to inhibit LSD1 can be ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
US Patent

Displayed 1 to 50 (of 159 total ) | Next | Last >>
Jump to: